Since the aberrant STAT3 activity observed in HPV16-induced cervical cancers is primarily manifested through persistent upstream signaling, in the absence of which STAT3 activity may revert back to its basal level, it gives a window of opportunity for effective therapeutic targeting by conventional herbal or rationally-designed STAT3 inhibitors (Fig. 6). This evidence concerns the gene STAT3 and cervical cancer.